For filings with the FSA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii

BlueCrest AllBlue Fund Limited

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Please refer to Sec.13

Yes

3. Full name of person(s) subject to the
notification obligation: iii

Barclays Plc

4. Full name of shareholder(s) 
 (if different from 3.):iv

5. Date of the transaction and date on
which the threshold is crossed or
reached: v

01/12/2009

6. Date on which issuer notified:

03/12/2009

7. Threshold(s) that is/are crossed or
reached: vi, vii

6 & 5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B13YVW48

GB00B13YXH37

GB00B13YXC81

12,212,359

2,257,204

290,380

12,212,359

2,257,204

290,380

Not reportable

Not reportable

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date xiii

Exercise/ 
Conversion Period xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Not reportable

Not reportable

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease
to hold:

12. Date on which proxy holder will cease to hold
voting rights:

13. Additional information:

On 1 December 2009, Barclays Group sold the Barclays Global Investors business, including Barclays Global Investors Ltd, Barclays Global Investors (Deutschland) Ltd, Barclays Global Investors N.A. and Barclays Global Fund Advisors to BlackRock Inc. Accordingly, holdings of Barclays Global Investors Ltd, Barclays Global Investors (Deutschland) Ltd, Barclays Global Investors N.A. and Barclays Global Fund Advisors are no longer attributable to the Barclays Group/Barclays plc and responsibility for making relevant shareholding disclosures relating to holdings of Barclays Global Investors Ltd, Barclays Global Investors (Deutschland) Ltd, Barclays Global Investors N.A. and Barclays Global Fund Advisors and other entities in the Barclays Global Investors business now lies with BlackRock.

14. Contact name:

James Gibson

15. Contact telephone number:

020 7116 7308

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name 

(including legal form of legal entities)

Barclays plc

Contact address 

(registered office for legal entities)

Level 29, 1 Churchill Place

London

E14 5HP

Phone number & email

0207 116 7308

Other useful information 

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name

Contact address

Phone number & email

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.